Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Kimia Biosciences

530313
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Kimia Biosciences Share price and Fundamental Analysis

View All Details
View All Details
Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products.
Company Incorporation1993
ChairmanSameer Goel
Head QuartersNew Delhi
Previous NameNA

Key Metrics

Market Cap (Cr)
230.84
PE Ratio
24.03
Industry P/E
30.53
PEG Ratio
-0.09
ROE
96.45%
ROCE
36.26%
ROA
8.64%
Total Debt (Cr)
33.03
Debt to Equity
3.31
Dividend Yield
0%
EPS
2.03
Book Value & P/B
2.11 x 23.17
Face Value
1
Outstanding Shares(Cr)
4.73
Current Ratio
1.27
EV to Sales
2.21

Stock Returns

1 Week+1.09%
1 Month+17.93%
6 Months-2%
1 Year-10.83%
3 Years+46.85%
5 Years+81.21%

CAGR

1 Year CAGR

Revenue Growth

-18.39%

Net Profit Growth

-43.24%

Operating Profit Growth

-124.08%

Dividend Growth

N/A

Stock Returns CAGR

-10.4%
no_data

No Stocks

Smart Score

2.4
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 74.94%

FIIs : 0.00%

DIIs : 0.38%

Public : 24.68%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Kimia Biosciences Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Kimia Biosciences Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products.

The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95.

During the 1998-99, the company has become a sick industrial units.

The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Hon'ble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Ho'ble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Hon'ble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview.

During the year 2017-18, the Scheme of Arrangement for Amalgamation of the Company with M/s Kimia Biosciences Limited was made effective from September 17, 2018. Upon Scheme of Amalgamation becoming effective on 17.09.2018, M/s. Kimia Biosciences Limited Holding Company having 37,28,100 Equity Shares (50.48%) of Rs. 10/- each of the Company got merged under reverse merger with the Company.

Kimia Biosciences Share Price

Kimia Biosciences share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Kimia Biosciences Market Cap

Market capitalization of Kimia Biosciences indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Kimia Biosciences is valued compared to its competitors.

Kimia Biosciences PE Ratio

Kimia Biosciences PE ratio helps investors understand what is the market value of each stock compared to Kimia Biosciences 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Kimia Biosciences PEG Ratio

The PEG ratio of Kimia Biosciences evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Kimia Biosciences ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Kimia Biosciences generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Kimia Biosciences ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Kimia Biosciences in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Kimia Biosciences Total Debt

Total debt of Kimia Biosciences shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Kimia Biosciences Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Kimia Biosciences compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Kimia Biosciences CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Kimia Biosciences over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Kimia Biosciences Technical Analysis

Technical analysis of Kimia Biosciences helps investors get an insight into when they can enter or exit the stock. Key components of Kimia Biosciences Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Kimia Biosciences shares often struggle to rise above due to selling pressure.

Kimia Biosciences Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Kimia Biosciences ’s financial health and profitability.

Kimia Biosciences Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Kimia Biosciences Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Kimia Biosciences Financials

The financials of Kimia Biosciences provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Kimia Biosciences Profit and Loss Statements

The profit and loss statement of Kimia Biosciences highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Kimia Biosciences .

Kimia Biosciences Balance Sheet

The balance sheet presents a snapshot of Kimia Biosciences ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Kimia Biosciences Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App